Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...

Announced positive topline data from the Phase 2a RIVER trial in patients with refractory chronic cough (RCC), making Haduvio the first therapy in clinical development ...

Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have earned a consensus rating of “Buy” from the ten brokerages ...

Four recent Broward schools property audits identified 274 pieces of equipment, mostly computers and other electronics, ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

We are not fully in the Q1 reporting cycle yet, as that will get going when the big banks report their March-quarter results ...

The poll’s findings come amid a rushed return-to-office push by the Trump administration, in conjunction with the firings of ...

On both sides of Wednesday’s game between the Philadelphia 76ers and the Oklahoma City Thunder, injury reports are loaded ...

Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical ...

The U.S. jewelry market grew 5% in 2024 to $85.4 billion, but affluent consumers are pulling back on planned jewelry ...

Explore top REIT picks for 2025! Discover how diversification, strong fundamentals, and sector-focused investing can deliver ...